Shifa Biomedical Corporation logo — company profile

Shifa Biomedical Corporation

Founded 2006 United States Malvern, United States 5 employees Seed Biotechnology, Pharmaceutical

General Information

Company Name Shifa Biomedical Corporation
Founded Year 2006
Location United States Malvern, United States +1
Employees 5
Industries Biotechnology, Pharmaceutical
Funding Stage Seed
Social

Get notified when Shifa Biomedical Corporation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Shifa Biomedical Corporation

Shifa Biomedical Corporation is a Malvern Pennsylvania-based drug discovery company founded in 2006. The company is focused on developing cost-effective drugs for cardiovascular disease treatment. Shifa utilizes various scientific methods such as molecular biology, biochemistry, crystallography, and medicinal, computational, and combinatorial chemistry for drug discovery. Their team is composed of highly-experienced scientists with expertise in early stage drug development. The company addresses the unmet need for more aggressive and selective targeted therapies for cardiovascular diseases. Shifa's focus lies on targeting PCSK9, the critical regulatory protein that controls the degradation of the LDL receptor in the liver, contributing to cholesterol homeostasis. They have identified a first-in-class small molecule lead compound, P-21, which interferes with the function of PCSK9 and significantly lowers LDL-C, offering a potential alternative to current treatment options. Shifa's efforts have attracted Seed Round investment from Xontogeny in May 2021. The company operates within the biotechnology and pharmaceutical industries and is headquartered in the United States. With its innovative approach to cardiovascular drug discovery and promising lead compound, Shifa Biomedical Corporation presents an intriguing opportunity for investment in the biopharmaceutical sector.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1 •••• •••• 12 May 2021

Shifa Biomedical Corporation Alternatives & Competitors

Shifa Biomedical Corporation vs

an innovation-driven biopharmaceutical company dedicated to the discovery and development of innovat...

210 employees
Shifa Biomedical Corporation vs
PAQ Therapeutics
PAQ Therapeutics United States

Pioneering a new approach to restoring health and curing disease through autophagy

Series B
12 employees
Biotechnology, Health Care
Shifa Biomedical Corporation vs
AZAFAROS B.V.
AZAFAROS B.V. The Netherlands

Navigating towards new treatment options for rare metabolic diseases

Series B
35 employees

FAQ About Shifa Biomedical Corporation

Shifa Biomedical Corporation (Shifa) is a drug discovery company in Malvern Pennsylvania. It is a privately held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease. Incorporated in 2006, Shifa has recognized expertise for the di...
Shifa Biomedical Corporation was founded in 2006.
Shifa Biomedical Corporation is headquartered in Malvern, United States.
Shifa Biomedical Corporation operates in the following industries: Biotechnology, Pharmaceutical.
Shifa Biomedical Corporation has approximately 5 employees.
Shifa Biomedical Corporation has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Shifa Biomedical Corporation include Shanghai Junshi Biosciences Co Ltd, PAQ Therapeutics, AZAFAROS B.V., Biomea Fusion, Symberix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Shifa Biomedical Corporation and Shanghai Junshi Biosciences Co Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Shifa Biomedical Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes